FI933167A - N-ALKYLKINUCLIDINIUMSALTER SOM SUBSTANS-P ANTAGONISTER - Google Patents

N-ALKYLKINUCLIDINIUMSALTER SOM SUBSTANS-P ANTAGONISTER Download PDF

Info

Publication number
FI933167A
FI933167A FI933167A FI933167A FI933167A FI 933167 A FI933167 A FI 933167A FI 933167 A FI933167 A FI 933167A FI 933167 A FI933167 A FI 933167A FI 933167 A FI933167 A FI 933167A
Authority
FI
Finland
Prior art keywords
antagonister
alkylkinuclidiniumsalter
substans
som
som substans
Prior art date
Application number
FI933167A
Other languages
Finnish (fi)
Other versions
FI933167A0 (en
Inventor
Iii John A Lowe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI933167A publication Critical patent/FI933167A/en
Publication of FI933167A0 publication Critical patent/FI933167A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI933167A 1991-01-10 1993-07-09 N-ALKYLKINUCLIDINIUMSALTER SOM SUBSTANS-P ANTAGONISTER FI933167A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63964491A 1991-01-10 1991-01-10
PCT/US1991/008836 WO1992012151A1 (en) 1991-01-10 1991-12-04 N-alkyl quinuclidinium salts as substance p antagonists

Publications (2)

Publication Number Publication Date
FI933167A true FI933167A (en) 1993-07-09
FI933167A0 FI933167A0 (en) 1993-07-09

Family

ID=24564973

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933167A FI933167A0 (en) 1991-01-10 1993-07-09 N-ALKYLKINUCLIDINIUMSALTER SOM SUBSTANS-P ANTAGONISTER

Country Status (14)

Country Link
EP (1) EP0566589A1 (en)
JP (1) JPH0733385B2 (en)
KR (1) KR930703311A (en)
AU (1) AU652407B2 (en)
CA (1) CA2100163A1 (en)
FI (1) FI933167A0 (en)
HU (1) HUT65612A (en)
IE (1) IE920071A1 (en)
IL (1) IL100584A (en)
MX (1) MX9200057A (en)
NZ (1) NZ241261A (en)
PT (1) PT100003A (en)
WO (1) WO1992012151A1 (en)
ZA (1) ZA92148B (en)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364943A (en) * 1991-11-27 1994-11-15 Pfizer Inc. Preparation of substituted piperidines
ES2063507T3 (en) * 1990-06-01 1995-01-01 Pfizer 3-AMINO-2-ARYL-QUINUCLIDINES, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US5521220A (en) * 1991-11-12 1996-05-28 Pfizer Inc. Acyclic ethylenediamine derivatives
DK0641328T3 (en) * 1992-05-18 2002-05-21 Pfizer Bridged, azabicyclic derivatives as substance P antagonists
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
WO1994003445A1 (en) * 1992-08-04 1994-02-17 Pfizer Inc. 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
GB9216911D0 (en) * 1992-08-10 1992-09-23 Merck Sharp & Dohme Therapeutic agents
US5387595A (en) * 1992-08-26 1995-02-07 Merck & Co., Inc. Alicyclic compounds as tachykinin receptor antagonists
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
IL116249A (en) * 1994-12-12 2003-07-06 Pfizer Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
FR2728169A1 (en) 1994-12-19 1996-06-21 Oreal USE OF A SUBSTANCE P ANTAGONIST FOR THE TREATMENT OF PRURITUS AND EYE OR PALPEBRAL DYSESTHESIA
FR2728165A1 (en) 1994-12-19 1996-06-21 Oreal USE OF AN ANTAGONIST OF SUBSTANCE P FOR THE TREATMENT OF SKIN REDNESS OF NEUROGENIC ORIGIN
FR2728166A1 (en) 1994-12-19 1996-06-21 Oreal TOPICAL COMPOSITION CONTAINING AN ANTAGONIST OF SUBSTANCE P
TW458774B (en) 1995-10-20 2001-10-11 Pfizer Antiemetic pharmaceutical compositions
FR2741262B1 (en) 1995-11-20 1999-03-05 Oreal USE OF A TNF-ALPHA ANTAGONIST FOR THE TREATMENT OF CUTANEOUS REDNESS OF NEUROGENIC ORIGIN
BR0015320A (en) 1999-11-03 2002-07-09 Albany Molecular Res Inc Compound, composition, methods of treating a disorder that is created by, or is dependent on, the decreased availability of serotonin, norepinephrine or dopamine, to inhibit the uptake of synaptic serotonin, dopamine and norepinephrine in a patient in need thereof, and kit
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
US7084152B2 (en) 2000-07-11 2006-08-01 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
CA2573271C (en) 2004-07-15 2015-10-06 Amr Technology, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
EP1888050B1 (en) 2005-05-17 2012-03-21 Merck Sharp & Dohme Ltd. cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid for the treatment of cancer
JP5258561B2 (en) 2005-07-15 2013-08-07 アルバニー モレキュラー リサーチ， インコーポレイテッド Aryl and heteroaryl substituted tetrahydrobenzazepines and their use to block reuptake of norepinephrine, dopamine and serotonin
KR20080048502A (en) 2005-09-29 2008-06-02 머크 앤드 캄파니 인코포레이티드 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2008039327A2 (en) 2006-09-22 2008-04-03 Merck & Co., Inc. Method of treatment using fatty acid synthesis inhibitors
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
MX2009007200A (en) 2007-01-10 2009-07-15 Angeletti P Ist Richerche Bio Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors.
JP5319518B2 (en) 2007-04-02 2013-10-16 Ｍｓｄ株式会社 Indoledione derivative
AU2008269154B2 (en) 2007-06-27 2014-06-12 Merck Sharp & Dohme Llc 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
JP2011515343A (en) 2008-03-03 2011-05-19 タイガー ファーマテック Tyrosine kinase inhibitor
AR071997A1 (en) 2008-06-04 2010-07-28 Bristol Myers Squibb Co CRYSTAL FORM OF 6 - ((4S) -2-METHYL-4- (2-NAFTIL) -1,2,3,4-TETRAHYDROISOQUINOLIN-7-IL) PIRIDAZIN-3-AMINA
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
UA105182C2 (en) 2008-07-03 2014-04-25 Ньюрексон, Інк. Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
KR20120023072A (en) 2009-05-12 2012-03-12 브리스톨-마이어스 스큅 컴퍼니 Crystalline forms of (s)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorohphenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
WO2010132437A1 (en) 2009-05-12 2010-11-18 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
AU2010247763B2 (en) 2009-05-12 2015-12-24 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
EA023838B1 (en) 2009-10-14 2016-07-29 Мерк Шарп Энд Домэ Корп. SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
EP2584903B1 (en) 2010-06-24 2018-10-24 Merck Sharp & Dohme Corp. Novel heterocyclic compounds as erk inhibitors
WO2012018754A2 (en) 2010-08-02 2012-02-09 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
CA2807307C (en) 2010-08-17 2021-02-09 Merck Sharp & Dohme Corp. Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina)
EP2608669B1 (en) 2010-08-23 2016-06-22 Merck Sharp & Dohme Corp. NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
US8946216B2 (en) 2010-09-01 2015-02-03 Merck Sharp & Dohme Corp. Indazole derivatives useful as ERK inhibitors
EP2615916B1 (en) 2010-09-16 2017-01-04 Merck Sharp & Dohme Corp. Fused pyrazole derivatives as novel erk inhibitors
US9260471B2 (en) 2010-10-29 2016-02-16 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
EP2654748B1 (en) 2010-12-21 2016-07-27 Merck Sharp & Dohme Corp. Indazole derivatives useful as erk inhibitors
AU2012245971A1 (en) 2011-04-21 2013-10-17 Piramal Enterprises Limited A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
US9023865B2 (en) 2011-10-27 2015-05-05 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
EP3453762B1 (en) 2012-05-02 2021-04-21 Sirna Therapeutics, Inc. Short interfering nucleic acid (sina) compositions
JP6280554B2 (en) 2012-09-28 2018-02-14 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Novel compounds that are ERK inhibitors
ME02925B (en) 2012-11-28 2018-04-20 Merck Sharp & Dohme Compositions and methods for treating cancer
TW201429969A (en) 2012-12-20 2014-08-01 Merck Sharp & Dohme Substituted imidazopyridines as HDM2 inhibitors
EP2951180B1 (en) 2013-01-30 2018-05-02 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as hdm2 inhibitors
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
WO2019094311A1 (en) 2017-11-08 2019-05-16 Merck Sharp & Dohme Corp. Prmt5 inhibitors
US11993602B2 (en) 2018-08-07 2024-05-28 Merck Sharp & Dohme Llc PRMT5 inhibitors
EP3833667B1 (en) 2018-08-07 2024-03-13 Merck Sharp & Dohme LLC Prmt5 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173445B (en) * 1984-03-16 1987-06-24 Guidotti & C Spa Labor AGENTS WITH ANTIBRONCOSPASTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
IT1230881B (en) * 1989-06-20 1991-11-08 Angeli Inst Spa DERIVATIVES OF R (-) 3-QUINUCLIDINOL

Also Published As

Publication number Publication date
JPH0733385B2 (en) 1995-04-12
IL100584A0 (en) 1992-09-06
PT100003A (en) 1993-02-26
HUT65612A (en) 1994-07-28
HU9301988D0 (en) 1993-12-28
IL100584A (en) 1995-10-31
ZA92148B (en) 1993-07-09
EP0566589A1 (en) 1993-10-27
WO1992012151A1 (en) 1992-07-23
CA2100163A1 (en) 1992-07-11
NZ241261A (en) 1994-05-26
IE920071A1 (en) 1992-07-15
AU652407B2 (en) 1994-08-25
AU9094791A (en) 1992-08-17
KR930703311A (en) 1993-11-29
MX9200057A (en) 1992-07-01
FI933167A0 (en) 1993-07-09
JPH05508866A (en) 1993-12-09

Similar Documents

Publication Publication Date Title
FI933167A (en) N-ALKYLKINUCLIDINIUMSALTER SOM SUBSTANS-P ANTAGONISTER
FI921182A (en) VELANGUMMI SOM SNABBT HYDRATISERAS
FI931229A0 (en) SOM GLANSPIGMENT LAEMPADE BLANDNINGAR
FI931111A0 (en) STAONGTVAOLSKOMPOSITIONER SOM INNEHAOLLER SACKAROS
FI934568A0 (en) HYDROFOBISITET SOM AOSTADKOMMITS MED METALLJONAKTIVERING
FI924982A (en) FRYSTORKAT PREPARAT SOM INNEHAOLLER MONOKLONAL MOTKROPP
FI931069A0 (en) KOLLOIDALT ROSTAT KAFFE SOM AROMATISERINGSPRODUKT
FI934225A (en) BIS-NAPHTHALIMIDER INNEHAOLLANDE UR AMINOSYROR HAERLEDDA KOPPLINGSAEMNEN SOM ANTICANCERMEDEL
FI934751A0 (en) EXTRACELLULAERA MATRISRECEPTORLIGANDER SOM MODULERAR LEUKOCYTFUNKTIONER
FI925044A (en) Foerfarande Foer aotervinning av svavelsyra ur svavelsyraavfall som innehaoller metalsulfat
FI933022A0 (en) RADIOSYSTEM SOM BILDAR EN TRAODLOES LOKALSLINGA
FI921666A (en) INDOLINO- OCH DIHYDROKINOLINFOERENINGAR SOM OEPPNARE AV KALIUMKANAL
FI923555A (en) FOERFARANDE FOER FRAMSTAELLNING AV MATTOR SOM BESTAOR AV MINST TVAO MED VARANDRA BUNDNA SKIKT
FI930342A0 (en) PENTAPEPTIDER SOM REGLERAR IMMUN- OCH NERVSYSTEM
FI924440A0 (en) HETEROCYCLISKA FOERENINGAR SOM ALDOSREDUKTASINHIBITORER
FI935826A0 (en) Kallsmoerjmedel med delvis neutraliserade phosphorsyraestrar som EP-tillsatsaemnen
FI931092A (en) VAPEN SOM INNEFATTAR EN STYRLINA
FI930618A (en) PROTEASER SOM FOERORSAKAR ONORMAL NEDBRYTNING AV AMYLOID-B-PROTEIN
FI914768A (en) FOER STOEDMURAR LAEMPAD STAOLPROFIL MED KANTIG SAMMANFOGNING SOM ARBETSOEPPNING
FI554U1 (en) Reklam som aendrar faerg
FI922997A (en) TUGGUMMI SOM INNEHAOLLER VERKSAMMA AEMNEN
FI361U1 (en) Loestagbar barnstol som tillaeggsutrustning till koekstrappa
FI910937A0 (en) ENGAONGSDAEMPARE FOER ANORDNING SOM HINDRAR MEDFALLANDE.
FI914989A0 (en) KRAFTVERK SOM ANVAENDER STROEMMANDE VATTEN.
FI913578A0 (en) DOERRSTRAPETS SOM MONTERAS I DOERROEPPNING.

Legal Events

Date Code Title Description
FD Application lapsed